by IonsGate Preclinical Services | Feb 18, 2022 | Drug Discovery
Canada/Europe, 2 February 2022 – Canadian CRO IonsGate Preclinical Services Inc (IonsGate), that is a market leader in preclinical research services, and European life sciences company InSilicoTrials just announced a partnership to leverage innovative technology like...
by IonsGate Preclinical Services | Jan 21, 2020 | Research
By Marc Pourrier and David Fedida Published: 19 January 2020 Abstract: There is a need for improved in vitro models of inherited cardiac diseases to better understand basic cellular and molecular mechanisms and advance drug development. Most of these diseases are...
by IonsGate Preclinical Services | Oct 18, 2019 | Discover
If you’ve watched TV more than once in the past decade, you’ve probably heard something about artificial intelligence (AI). The prospect of human-like intelligence in machines has captivated our collective imagination since the first computers made their first...
by IonsGate Preclinical Services | Aug 27, 2019 | Discover
Safety and efficacy are two critical components of getting a new drug approved, however demonstrating these factors can be difficult in some classes of drugs. Medications that affect cardiac tissue require high scrutiny, as both their potential benefits and risks to...
by IonsGate Preclinical Services | Aug 19, 2019 | Discover
Safety assessments are a critical component of taking a potential pharmaceutical compound down the path from discovery to prescription drug. However, it is often difficult to assess whether a drug will affect everyone the same. Over the past few decades, doctors and...
